3,4-dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells

Peritoneal Dialysis International

Volumn 29, Issue 1, 2009, Pages 44-51

  Lee, Duk Hyun ^a   Choi, Soon Youn ^a   Ryu, Hye Myung ^a   Kim, Chan Duck ^a   Park, Sun Hee ^a   Chung, Ho Young ^a   Kim, In San ^a   Kim, Yong Lim ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

3,4 DGE; Apoptosis; Caspase; Peritoneal mesothelial cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3,4 DIDEOXYGLUCOSONE 3 ENE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; GLUCOSE DEGRADATION PRODUCT; PROCASPASE 3; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; 3,4-DIDEOXYGLUCOSONE-3-ENE; GLYCOGEN PHOSPHORYLASE; PYRONE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESOTHELIUM CELL; NICK END LABELING; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; METABOLISM; PATHOLOGY; PERITONEUM;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELLS, CULTURED; EPITHELIAL CELLS; FLOW CYTOMETRY; GLYCOGEN PHOSPHORYLASE; HUMANS; IN SITU NICK-END LABELING; PERITONEUM; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRONES;

EID: 65349127017     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900107     Document Type: Article

References (19)

1. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 1997; 45:50-6.
2. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W. High-glucose - triggered apoptosis in cultured endothelial cells. Diabetes 1995; 44: 1323-7.
3. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1998; 4:1421-4.
4. Witowski J, Jorres A. Glucose degradation products: relationship with cell damage. Perit Dial Int 2600; 20(Suppl 2):S31-6.
5. Catalan MP, Reyero A, Egido J, Ortiz A. Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases. J Am Soc Nephrol 2001; 12:2442-9.
6. Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A. 3,4-dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002; 62:697-703.
7. Justo P, Sanz AB, Egido J, Ortiz A. 3,4-dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 2005; 54:2424-9.
8. Catalan MP, Santamaria B, Reyero A, Ortiz A, Egido J, Ortiz A. 3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis. Kidney Int 2005; 68:1303-11.
9. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001; 12:2434-41.
10. Kato F, Mizukoshi S, Aoyama Y, Matsuoka H, Tanaka H, Nakamura K, et al. Immunosuppressive effects of 3,4-di-deoxyglucosone-3-ene, an intermediate in the Maillard reaction. J Agric Food Chem 1994; 42:2068-73.
11. Erixon M, Linden T, Kjellstrand P, Carlsson O, Ernebrant M, Forsback G, et al. PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization. Perit Dial Int 2004; 24:392-8.
12. Ortiz A, Wieslander A, Linden T, Santamaria B, Sanz A, Justo P, et al. 3,4-DGE is important for side effects in peritoneal dialysis. What about its role in diabetes? Curr Med Chem 2006; 13:2605-702.
13. Ortiz A. Nephrology forum: Apoptotic regulatory proteins in renal injury. Kidney Int 2000; 58:467-85.
14. Ortiz A, Catalan MP. Will modulation of cell death increase PD technique survival? Perit Dial Int 2004; 24:105-14.
15. Green DR, Kroemer G. Pharmacological manipulation of cell death: clinical applications in sight? J Clin Invest 2005; 115:2610-17.
16. Adams JM, Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 2007; 19: 488-96.
17. Brunet CL, Gunby RH, Benson RS, Hickman JA, Watson AJ, Brady G. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ 1998; 5:107-15.
18. Lorz C, Justo P, Sanz A, Subira D, Egido J, Ortiz A. Paracetamol-induced renaltubular injury: a role for ER stress. J Am Soc Nephrol 2004; 15:380-9.
19. FaucherK, Rabinovitch-Chable H, Cook-Moreau J, Barriere G, Sturtz F, Rigaud M. Overexpression of human GPX1 modifies Bax to Bcl-2 apoptotic ratio in human endothelial cells. Mol Cell Biochem 2005; 277:81-7.